Isolation of recombinant MVA using F13L selection

Methods Mol Biol. 2012:890:93-111. doi: 10.1007/978-1-61779-876-4_5.

Abstract

Modified vaccinia virus Ankara (MVA) has become a widely used vector for vaccine and laboratory purposes. Despite significant advances in recombinant MVA technology, the isolation of recombinant viruses remains a tedious and difficult process. This chapter describes the use of an efficient and easy-to-use selection system adapted for MVA. The system is based on the requirement of the viral gene F13L for efficient virus spread in cell culture, which results in a severe block in virus transmission when F13L gene is deleted (Blasco R, Moss B. J Virol 65:5910-5920, 1991; Blasco R, Moss B. J Virol 66:4170-4179, 1992). The insertion of foreign genes in the MVA genome is accomplished by recombination of a transfected plasmid carrying the foreign genes and the F13L with the genome of an F13L knockout virus. Subsequently, selection of virus recombinants is carried out by serial passage and/or plaque purification of viruses that have recovered the F13L gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Cells, Cultured
  • Cloning, Molecular
  • Cricetinae
  • DNA, Recombinant
  • Gene Knockout Techniques
  • Genetic Markers
  • Membrane Proteins / genetics*
  • Promoter Regions, Genetic
  • Transduction, Genetic
  • Vaccinia virus / genetics*
  • Vaccinia virus / growth & development
  • Vaccinia virus / isolation & purification*
  • Viral Envelope Proteins / genetics*
  • Viral Load
  • Virus Cultivation

Substances

  • DNA, Recombinant
  • Genetic Markers
  • Membrane Proteins
  • Viral Envelope Proteins
  • p37 protein, Vaccinia virus